Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4- The Role of Montelukast on Perennial Rhinitis and Associated Sleep Disturbance and Daytime Somnolence

NCT00590772 is registered in ClinicalTrials.gov with Penn State University as lead sponsor.

NCT NCT00590772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00590772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4- The Role of Montelukast on Perennial Rhinitis and Associated Sleep Disturbance and Daytime Somnolence
Lead sponsor
Penn State University
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2003
Completion date
January 31, 2009
Enrollment
31 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

perennial allergic rhinitis